BABEL Ventures

BABEL Ventures is a pioneering early-stage consumer biotech fund based in Silicon Valley, founded in 2017. The firm focuses on harnessing biology as a technology to solve the world's most intractable problems — spanning food security, climate, and human health — while delivering outsized financial returns. BABEL typically writes the first institutional check into companies at their most vulnerable but highest-upside stage, backing visionary, science-credentialed founder teams with deep domain expertise and a commitment to sustainability and positive impact. The fund invests across consumer biotech verticals including alternative proteins and cell-cultured food, sustainable materials and packaging, personal care and wellness, DNA/longevity health, and AI-powered consumer platforms. BABEL explicitly avoids pure hardware plays, pharmaceutical-only approaches, and companies without strong technical or scientific founder credibility. Since launch, the portfolio of 33+ companies has produced returns as high as 40x, with multiple companies going public or raising significant follow-on capital.